E. A. Ostermeyer

发表

Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

M. King, Å. Borg, O. Johannsson, 1996, American journal of human genetics.

22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors.

Ming K. Lee, P. Welcsh, C. Szabo, 1995, Genomics.

Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1.

M. King, F. Collins, F. Couch, 1996, Genomics.

M. King, J. Boyd, Ming K. Lee, 2006 .

The search for BRCA1.

M. King, J. Boyd, C. Szabo, 1994, Cancer research.

Green pigs, red herrings, and a golden hoe: a retrospective on the identification of BRCA1 and the beginning of its characterization.

M. King, P. Dowd, L. Friedman, 1994, Cold Spring Harbor symposia on quantitative biology.

Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

Patrick Dowd, Eric D. Lynch, M. King, 1994, Nature Genetics.

Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.

Hanlee P. Ji, M. King, K. Heimdal, 1997, American journal of human genetics.

Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.

M. King, E. Goode, Ming K. Lee, 1995, American journal of human genetics.

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

M. Skolnick, F. Couch, S. Ingles, 1995, JAMA.